Extracellular matrix–targeted TNC-scFv armoring enhances CAR T cell persistence and antitumor activity in solid tumors
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Together, these results establish extracellular matrix–directed armoring as a generalizable strategy to improve CAR T cell therapy for solid tumors.
Appeared: Sunday, October 11. Science Advances. Peer-reviewed journal.